Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes.

It is widely believed that viral clearance is mediated principally by the destruction of infected cells by CTLs. In this report, we use a transgenic mouse model of HBV replication to demonstrate that this assumption may not be true for all viruses. We find that adoptively transferred virus-specific CTLs can abolish HBV gene expression and replication in the liver without killing the hepatocytes. This antiviral function is mediated by IFN gamma and TNF alpha secreted by the CTL or by the antigen-nonspecific macrophages and T cells that they activate following antigen recognition. These cytokines activate two independent virocidal pathways: the first pathway eliminates HBV nucleocapsid particles and their cargo of replicating viral genomes, while the second pathway destabilizes the viral RNA. Intracellular viral inactivation mechanisms such as these could greatly amplify the protective effects of the immune response, while failure of such mechanisms could lead to viral persistence or to the death of the host.

[1]  M. Oldstone,et al.  Biology of cloned cytotoxic T lymphocytes specific for lymphocytic choriomeningitis virus: clearance of virus in vivo , 1984, Journal of virology.

[2]  T. Wu,et al.  Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement , 1992, Journal of virology.

[3]  G. Michalopoulos Liver regeneration: molecular mechanisms of growth control , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[4]  W H Lamers,et al.  Hepatic enzymic zonation: A reevaluation of the concept of the liver acinus , 1989, Hepatology.

[5]  S. Thorgeirsson,et al.  Expression of hepatic transcription factors during liver development and oval cell differentiation , 1994, The Journal of cell biology.

[6]  S. Zhou,et al.  Cys residues of the hepatitis B virus capsid protein are not essential for the assembly of viral core particles but can influence their stability , 1992, Journal of virology.

[7]  J. Cullen,et al.  Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks , 1994, Journal of virology.

[8]  D. Moskophidis,et al.  Mechanism of recovery from acute virus infection. I. Role of T lymphocytes in the clearance of lymphocytic choriomeningitis virus from spleens of mice. , 1985, Journal of immunology.

[9]  R. Zinkernagel,et al.  Resistance of lymphocytic choriomeningitis virus to alpha/beta interferon and to gamma interferon , 1994, Journal of virology.

[10]  Hans Hengartner,et al.  Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice , 1994, Nature.

[11]  E. Martz,et al.  CTL: virus control cells first and cytolytic cells second? DNA fragmentation, apoptosis and the prelytic halt hypothesis. , 1989, Immunology today.

[12]  B. Torbett,et al.  Patterns of cytokine gene expression by CD4+ T cells from young and old mice. , 1993, Journal of immunology.

[13]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[14]  F. Chisari,et al.  Tumor necrosis factor alpha negatively regulates hepatitis B virus gene expression in transgenic mice , 1992, Journal of virology.

[15]  F. Chisari,et al.  Class I-restricted cytotoxic T lymphocytes are directly cytopathic for their target cells in vivo. , 1994, Journal of immunology.

[16]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[17]  J. Summers,et al.  Phosphorylation of the duck hepatitis B virus capsid protein associated with conformational changes in the C terminus , 1994, Journal of virology.

[18]  R. Ueda,et al.  Immune function in mice lacking the perforin gene. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[19]  F. Chisari,et al.  Posttranscriptional clearance of hepatitis B virus RNA by cytotoxic T lymphocyte-activated hepatocytes. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Cullen,et al.  Woodchuck hepatitis virus infections: very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte , 1994, Journal of virology.

[21]  R. Schreiber,et al.  Generation and characterization of hamster monoclonal antibodies that neutralize murine tumor necrosis factors. , 1989, Journal of immunology.

[22]  F. Chisari,et al.  Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[23]  F. Chisari,et al.  Hepatitis B virus nucleocapsid particles do not cross the hepatocyte nuclear membrane in transgenic mice , 1994, Journal of virology.

[24]  F. Chisari,et al.  Interleukin-2 and alpha/beta interferon down-regulate hepatitis B virus gene expression in vivo by tumor necrosis factor-dependent and -independent pathways , 1994, Journal of virology.

[25]  E. Tan,et al.  Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. , 1988, Journal of immunological methods.

[26]  R. Palmiter,et al.  Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice , 1989, Cell.

[27]  F. Chisari,et al.  High-level hepatitis B virus replication in transgenic mice , 1995, Journal of virology.

[28]  R. Palmiter,et al.  Expression of hepatitis B virus large envelope polypeptide inhibits hepatitis B surface antigen secretion in transgenic mice , 1986, Journal of virology.

[29]  H. Varmus,et al.  The molecular biology of the hepatitis B viruses. , 1987, Annual review of biochemistry.

[30]  F. Lehmann-Grube,et al.  Control of acute infection with lymphocytic choriomeningitis virus in mice that cannot present an immunodominant viral cytotoxic T lymphocyte epitope. , 1992, Journal of immunology.

[31]  F. Chisari,et al.  Hepatitis B virus immunopathogenesis. , 1995, Annual review of immunology.

[32]  F. Chisari,et al.  Interleukin-2 downregulates hepatitis B virus gene expression in transgenic mice by a posttranscriptional mechanism. , 1993, Journal of virology.

[33]  D. Moskophidis,et al.  Recovery from Acute Virus Infection , 1988, Annals of the New York Academy of Sciences.

[34]  R. Schreiber,et al.  Monoclonal antibodies to murine gamma-interferon which differentially modulate macrophage activation and antiviral activity. , 1985, Journal of immunology.

[35]  J. Summers,et al.  Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells , 1986, Cell.

[36]  F. Chisari,et al.  Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis , 1993, The Journal of experimental medicine.